New president and CEO at Catalent
This article was originally published in Scrip
Catalent Pharma Solutions (US), a provider of development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies, has appointed John Chiminski president and chief executive officer. George Fotiades, who has been serving as interim president and CEO, will step down from the role, but will continue to serve as chairman of Catalent's board. Mr Chiminski most recently served as president and CEO of GE Medical Diagnostics.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.